Recurrence rate of perianal and intra-anal genital warts treated with aminolevulinic acid photodynamic therapy: a meta-analysis

采用氨基乙酰丙酸光动力疗法治疗肛周和肛内生殖器疣的复发率:一项荟萃分析

阅读:1

Abstract

OBJECTIVE: This meta-analysis and systematic review aimed to evaluate the recurrence rate and clinical efficacy of aminolevulinic acid photodynamic therapy (ALA-PDT) in the treatment of perianal and intra-anal genital warts. METHODS: We systematically searched the China National Knowledge Infrastructure (CNKI), Wanfang Data, VIP, Chinese Biomedicine (CBM), PubMed, and Cochrane Library databases from their inception to April 1, 2024, for randomized controlled trials (RCTs) investigating ALA-PDT for perianal and intra-anal genital warts. Study quality was assessed using the Cochrane Collaboration's risk of bias tool, and statistical analysis was performed using RevMan 5.3 software. RESULTS: After rigorous screening, 32 RCTs involving 2,538 patients were included. The recurrence rate of perianal and intra-anal genital warts treated with ALA-PDT was significantly lower than that in conventional treatment groups (OR = 0.17, 95% CI [0.13, 0.22], P < 0.00001). While ALA-PDT monotherapy demonstrated lower efficacy compared to conventional treatments (OR = 0.49, 95% CI [0.29, 0.85], P = 0.01), ALA-PDT combined with other therapeutic modalities showed superior clinical outcomes (OR = 4.72, 95% CI [3.53, 6.32], P < 0.00001). CONCLUSION: ALA-PDT effectively reduces recurrence rates of perianal and intra-anal genital warts and enhances treatment efficacy when used in combination with conventional therapies. As all included studies were conducted in China, further multinational RCTs are warranted to validate these findings across diverse populations. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024501535.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。